Thienopyrrole compounds
US11661431B2 · kind B2 · utility
0Cited by
3References
53Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 15, 2022 |
| Grant date | May 30, 2023 |
| Priority date | — |
| Expiry date | Apr 15, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure relates generally to certain compounds, pharmaceutical compositions comprising said compounds, and methods of making and using said compounds and pharmaceutical compositions. The compounds and compositions provided herein may be used for the treatment or prevention of an autoimmune disease and/or inflammatory condition, including systemic lupus erythematosus and cutaneous lupus erythematosus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.